# Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel in Gastric Cancer Patients With Peritoneal Metastasis

> **NCT04913662** · PHASE1 · UNKNOWN · sponsor: **Seoul National University Bundang Hospital** · enrollment: 18 (estimated)

## Conditions studied

- Stomach Neoplasm
- Peritoneal Metastases

## Interventions

- **PROCEDURE:** Pressurized Intraperitoneal Aerosol Chemotherapy

## Key facts

- **NCT ID:** NCT04913662
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-26
- **Primary completion:** 2022-04-26
- **Final completion:** 2022-06-30
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2021-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04913662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04913662, "Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel in Gastric Cancer Patients With Peritoneal Metastasis". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT04913662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*